Shares outstanding · 2011–2025
Biomarin Pharmaceutical shares outstanding
192M+0.8% · FY2025
Biomarin Pharmaceutical (BMRN) reported 192M in shares outstanding for fiscal 2025, +0.8% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 192M | +0.8% | Open → |
| FY20242024-12-31 | 191M | +1.1% | Open → |
| FY20232023-12-31 | 189M | +1.3% | Open → |
| FY20222022-12-31 | 186M | +1.3% | Open → |
| FY20212021-12-31 | 184M | +1.1% | Open → |
| FY20202021-02-12 | 182M | +1.1% | Open → |
| FY20192020-02-12 | 180M | +0.9% | Open → |
| FY20182019-02-12 | 178M | +1.3% | Open → |
| FY20172018-02-13 | 176M | +1.9% | Open → |
| FY20162017-02-13 | 173M | +7.0% | Open → |
| FY20152016-02-12 | 162M | +1.5% | Open → |
| FY20142015-02-13 | 159M | +10.8% | Open → |
| FY20132014-02-14 | 144M | +14.2% | Open → |
| FY20122012-12-31 | 126M | +9.3% | Open → |
| FY20112012-02-13 | 115M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +3.7%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biomarin Pharmaceutical shares outstanding |url=https://companiesranked.com/en/company/biomarin-pharmaceutical/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biomarin Pharmaceutical shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/biomarin-pharmaceutical/shares-outstandingBibTeX
@misc{companiesranked-en-company-biomarin-pharmaceutical-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Biomarin Pharmaceutical shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biomarin-pharmaceutical/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001048477-26-000016 · August 6, 2026
{{cite web |title=Biomarin Pharmaceutical shares outstanding — 10-Q (0001048477-26-000016) |url=https://www.sec.gov/Archives/edgar/data/1048477/000104847726000016/bmrn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.